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Bovine F1-ATPase covalently inhibited with 4-chloro-7-
nitrobenzofurazan: the structure provides further support for a
rotary catalytic mechanism
George L Orriss, Andrew GW Leslie, Kerstin Braig and John E Walker*
Background:  F1-ATPase is the globular domain of F1F0-ATP synthase that
catalyses the hydrolysis of ATP to ADP and phosphate. The crystal structure of
bovine F1-ATPase has been determined previously to 2.8 Å resolution. The
enzyme comprises five different subunits in the stoichiometry α3β3γδε; the three
catalytic β subunits alternate with the three α subunits around the centrally
located single γ subunit. To understand more about the catalytic mechanism,
F1-ATPase was inhibited by reaction with 4-chloro-7-nitrobenzofurazan (NBD-
Cl) and the structure of the inhibited complex (F1–NBD) determined by X-ray
crystallography.
Results:  In the structure the three β subunits adopt a different conformation
with different nucleotide occupancy. NBD-Cl reacts with the phenolic oxygen of
Tyr311 of the βE subunit, which contains no bound nucleotide. The two other
catalytic subunits βTP and βDP contain bound adenylyl-imidodiphosphate (AMP-
PNP) and ADP, respectively. The binding site of the NBD moiety does not
overlap with the regions of βE that form the nucleotide-binding pocket in
subunits βTP and βDP nor does it occlude the nucleotide-binding site. Catalysis
appears to be inhibited because neither βTP nor βDP can accommodate a
Tyr311 residue bearing an NBD group.
Conclusions:  The results presented here are consistent with a rotary catalytic
mechanism of ATP synthesis and hydrolysis, which requires the sequential and
concerted participation of all three catalytic sites. NBD-Cl inhibits the enzyme
by preventing the modified subunit from adopting a conformation that is
essential for catalysis to proceed.
Introduction
F1-ATPase is the globular catalytic domain of the mem-
brane-bound F1F0-ATP synthase; it can be detached intact
from the membrane and hydrolyses ATP to ADP and phos-
phate. F1-ATPase is composed of five different polypep-
tides in the ratio α3β3γδε [1–3]. Their combined molecular
mass is 371,000. 4-Chloro-7-nitrobenzofurazan (NBD-Cl)
(Figure 1) inhibits ATP hydrolysis by the bovine enzyme
by reacting specifically with Tyr311, and complete inhibi-
tion is obtained by modification of this residue in only one
of the three catalytic β subunits [4–6]. The F1-ATPases
from Escherichia coli [7], the thermophilic bacterium PS3 [8]
and chloroplasts [9] are also inhibited by the reaction of
NBD-Cl with the equivalent tyrosine residue. The ATP
synthesis activity of F1F0-ATP synthase is also inhibited by
modification of Tyr311 with NBD-Cl [10].
NBD-Cl is highly reactive towards nucleophiles such as
sulphydryl [4,11,12] and amino groups [13]. The Tyr–O–
NBD linkage is unstable at alkaline pH, and at pH 9.0 the
NBD group transfers from the tyrosine to a lysine residue
in the same β subunit [13]. This lysine has been identified
as Lys162 in the phosphate-binding loop (P loop) [14],
and not Lys401 as initially proposed [15]. This transfer
reaction can be prevented by reduction with sodium
dithionite, which reduces the nitro group of the NBD
moiety to the more stable amino derivative [5]. In the
present work, F1-ATPase inhibited with NBD-Cl and
reduced with dithionite has been crystallised, and the
structure of the inhibited enzyme has been solved.
In the structure of bovine F1-ATPase [16], the three cat-
alytic β subunits alternate with the three non-catalytic
α subunits, around the centrally located single γ subunit.
In crystals of bovine F1-ATPase grown in the presence of
adenylyl-imidodiphosphate (AMP-PNP) and ADP, each
of the three chemically identical β subunits adopts a dif-
ferent conformation, with different nucleotide occupancy.
One β subunit (βTP) has AMP-PNP bound and the second
(βDP) has ADP bound. The third β subunit (βE) has no
bound nucleotide at all despite the presence of excess
nucleotides in the mother liquor. The α subunits are
referred to as αTP, αDP and αE according to the catalytic
interface in which they participate. Many features in the
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structure of bovine F1-ATPase suggest a rotary catalytic
mechanism, in which the three catalytic β subunits are
interconverted through different conformations by a rota-
tion of the γ subunit relative to the α3β3 subcomplex. The
structure is consistent with Boyer’s ‘binding change mech-
anism’ of ATP synthesis and hydrolysis by F1F0-ATP
synthase [17]. The rotation of the single-copy γ subunit
relative to the α3β3 assembly has been visualised directly
in a bacterial α3β3γ complex [18]. The structure of bovine
F1-ATPase inhibited by NBD-Cl is consistent with a
cyclic catalytic mechanism.
The structure of bovine F1-ATPase covalently modified
by NBD-Cl (F1–NBD) is presented here at 3 Å resolution.
The enzyme was inhibited to greater than 99% by reaction
with 0.1 mM NBD-Cl, and only one of the three β sub-
units, namely βE, had reacted with the reagent at Tyr311.
The corresponding residues in the βDP and βTP subunits
are buried at the β interface with the adjacent α subunits
and are inaccessible to the reagent. The inhibitor appears
to act by preventing the βE conformation from converting
to a productive nucleotide-binding state. This proposal is
consistent with a cyclic catalytic mechanism in which all
three of the β subunits participate sequentially.
Results and discussion
Inhibition reaction
The UV spectrum of the NBD-Cl inhibited enzyme has
an absorbance maximum at 385 nm which is consistent
with reaction with the phenolic oxygen of a tyrosine [4].
This treatment resulted in the loss of 80% of the initial
ATPase activity within 10 min. After 45 min, more than
99% of the activity had been lost (Figure 2). Further incu-
bation did not lead to loss of the residual ATPase activity.
Structure determination
The structure of the NBD-Cl-inhibited form of bovine
mitochondrial F1-ATPase has been refined at 3 Å resolu-
tion, with a final R factor of 20.7% and a free R factor of
29.7%. Data processing and refinement statistics are pre-
sented in Table 1. The stereochemistry of the final model
was good, with 86.8% of residues having mainchain torsion
angles within the most favoured regions of the Ramachan-
dran plot [19] and none in the disallowed regions.
The final model consists of residues 24–510 for the αE
subunit, residues 24–400 and 415–510 for the αTP subunit
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Figure 1
The chemical structure and reaction of 
NBD-Cl with bovine F1-ATPase (designated
MF1).
Figure 2
The kinetics of inhibition of F1-ATPase by NBD-Cl. The inhibition of the
enzyme by 0.1 mM NBD-Cl over time was followed by measuring the
residual ATPase activity at 30°C.
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and residues 19–510 for the αDP subunit, residues 9–474 for
each of the β subunits and residues 1–44, 77–90 and
209–272 for the γ subunit.
Overall molecular conformation
The refined F1–NBD structure is very similar to the
native F1-ATPase structure with bound AMP-PNP and
ADP [16]. No significant changes were observed in the
quaternary and tertiary structure or in the residues which
form the NBD-binding pocket. A subunit by subunit com-
parison with the native AMP-PNP/ADP bound enzyme
gave root mean square (rms) differences for all mainchain
atoms of 0.56 Å, 0.58 Å and 0.49 Å for the αTP, αDP and
αE subunits, respectively, 0.41 Å, 0.58 Å and 0.53 Å for theβTP, βDP and βE subunits, and 0.71 Å for the γ subunit,
compared with a value of 0.55 Å for the entire structure.
The higher value for the γ subunit is a reflection of the
higher temperature factors associated with this subunit.
The NBD-binding site
The NBD-binding site is in the central nucleotide-binding
domain of the βE subunit (residues 83–363), but does not
encompass sidechains that become involved in nucleotide
binding in subunits βDP and βTP. The modified Tyr311 is
found directly at the ‘open’ αE–βE interface, with the
NBD group pointing away from the βE subunit towards
the adjacent αE subunit. The NBD moiety sits in a loose
pocket (referred to as the NBD-binding pocket). The
location of this pocket in the overall structure of the
enzyme and a detailed view at the αE–βE interface are
shown in Figures 3a and b, respectively.
The NBD-binding pocket is quite open, with no hydro-
gen bonds between the protein and the NBD ring. Only
two protein atoms, αEIle343(CG2) and βEAsp315(OD2), are
within 4 Å of the NBD ring. This provides an explanation
for the relatively weak density and high thermal parameters
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Figure 3
Position of the NBD-binding pocket within the
structure of the F1–NBD complex. The α andβ subunits are shown in red and yellow,
respectively. The single γ subunit is in blue
and the NBD group in green. (a) The position
of the NBD group in the βE subunit. There are
no interactions between NBD and the
γ subunit. (b) The NBD-binding pocket viewed
from the central γ subunit; the pocket is
located at the αE–βE interface.
Table 1
Crystallographic statistics.
Space group P212121
Unit-cell dimensions (Å) 281.0 × 106.6 × 138.8
Resolution (Å) 20.0–3.0
Reflections 70,240
Rejected measurements (%)* 0.6
Rmerge† 0.088 (0.304)
Completeness 0.972 (0.98)
Multiplicity 2.5 (2.6)
Mean 〈F/σ(F)〉 20.1 (7.17)
Resolution limits for refinement (Å) 6.0–3.0
Number of reflections 66,714
F1-ATPase atoms‡ 22,881
NBD atoms‡ 10
Water molecules‡ 164
R factor (%)§ 20.7 (29.3)
Free R factor (%)¶ 29.7 (36.1)
Rms deviation of bonds (Å) 0.005
Rms deviation of angles (°) 0.994
Values in parentheses are for the highest resolution shell.
*Measurements with intensities differing more than 3.5σ(I) from the
weighted mean were rejected. †Rmerge = Σh Σi|I (h)–I(h)i |/ Σh Σi I(h)i,
where I(h) is the weighted mean intensity after rejections. The
contributing reflections were weighted by their standard deviations,
which were determined by adjusting the measured standard deviation
to reflect the observed differences between symmetry-related
reflections. ‡Hydrogen atoms were excluded. §The R factor is defined
as Σh | Fo–Fc |/ Σh Fo, where Fo and Fc are the observed and calculated
structure-factor amplitudes, respectively, and was determined using
98% of the data. ¶The free R factor [30] was determined from the
residual 2% of the data.
for the NBD moiety. The pocket itself is composed of
residues Val334, Ser335, Thr340, Ile343 and Phe351 of the
αE subunit, and residues Val312, Pro313, Ala314 and
Asp315 from the βE subunit (Figure 4). The top of the
pocket is defined by Val334, Ser335 and Thr340 of the
αE subunit, and residues Pro313 and Ala314 from theβE subunit. Residue αEIle343 is in middle of the pocket,
and αEPhe351, βEVal312 and βEAsp315 form the bottom
of the pocket.
The mechanism of inhibition of F1-ATPase by NBD-Cl
The catalytic cycle of the enzyme requires concerted con-
formational changes in all three catalytic β subunits, in
which they pass through the three states ‘open’, ‘loose’
and ‘tight’ as proposed in the binding change mechanism
[17]. The open site has a low affinity for substrate, the
loose site has loosely bound substrate and the tight site
contains tightly bound products. In the structure, the
βE subunit seems to correspond to the open site, and theβTP and βDP subunits appear to correspond to the loose
and tight sites, respectively. In the hydrolytic cycle each
site proceeds unhindered between the open, loose and
tight conformations cooperatively and sequentially, with
all three catalytic β subunits participating in catalysis.
It is clear from the structure, that only Tyr311 in the
βE subunit is accessible to modification by NBD-Cl. In
subunits βTP and βDP, this amino acid is buried in the
α–β subunit interfaces and is inaccessible to the reagent.
The structure also shows that NBD-Cl does not act as a
nucleotide analogue, contrary to a previous proposal [7]. It
is 13 Å distant from the P-loop residues which are involved
in nucleotide binding in subunits βDP and βTP, and it does
not occlude the potential nucleotide pocket [20]. 
It would appear from the structure that the inhibition
of F1-ATPase is due to the NBD group preventing the
required interconversion between different conformations
(Figure 5). The interconversion is blocked as an NBD
group on Tyr311 cannot be accommodated in either the
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Figure 4
Stereo view of the amino acid residues that
form the NBD-binding pocket. All the residues
shown lie within 5 Å of any atom on the NBD
ring. Atoms are shown in standard colours. 
Figure 5
Mechanism of inhibition of F1-ATPase by the
NBD moiety. The dark blue and light blue
regions represent parts of the β and
α subunits, respectively. The NBD ring is
shown in orange, and the yellow circles
indicate the positions of the amino acids in
the α and β subunits that form the NBD
pocket. The positions of the P-loop residues
Ala158, Lys162 and Thr163 in the βE subunit
are shown in green. (a) The NBD-binding
pocket at the αE–βE interface, and (b) the
equivalent region in the αTP–βTP interface. In
(b) this region is unable to accommodate an
NBD moiety on Tyr311. If present, it would
make many short contacts (< 3 Å) to the
residues that are shown, excepting the P-loop
residues (shown in green).
βTP or βDP subunits because the NBD ring would make
unfavourable steric clashes with many mainchain and
sidechain atoms. The synthetic and hydrolytic activities of
F1F0-ATP synthase are both inhibited by modification
with NBD-Cl [10], as both of these activities require the
βE conformation to convert to a productive nucleotide-
binding state.
Under alkaline conditions the NBD moiety can transfer
from Tyr311 to Lys162 [13]. The NBD group is about 13 Å
from this residue in the βE subunit, and so it is unlikely that
the NBD moiety is transferred directly in this conformation
from Tyr311 to Lys162. If the βE subunit were to begin
to convert to conformations similar to those of the βTP orβDP subunits as the cyclic mechanism demands, however,
then model building shows that a change in the χ1 side-
chain angle of Tyr311 can bring the NBD ester linkage
within 3 Å of the γ-phosphate, facilitating transfer to the
ε-amino group of Lys162. A similar explanation can be
invoked to explain the transfer from Tyr311 to the thiol
group of the nucleotide analogue P1-(5′-adenosyl)-P2-N-(2-
mercaptoethyl)diphosphoramidate (AMEDA) [21]. In both
cases, the requirement for a significant conformational
change is consistent with the slow transfer rate that is
observed (approximately 60 min in the case of AMEDA,
and 5 h for the tyrosine to lysine transfer). 
There are conflicting results in the literature on the stoi-
chiometry of nucleotide binding to the NBD-Cl inhibited
enzyme. Cross and Nalin [22] found that three molecules
of AMP-PNP could be bound at catalytic sites in the
NBD-Cl inhibited mitochondrial F1-ATPase, whereas
Weber et al. [20] report that only two catalytic sites are
occupied in NBD-Cl inhibited E. coli F1-ATPase, even at
high nucleotide concentrations. In the F1–NBD structure,
nucleotides are bound at two catalytic sites, as in the native
F1 structure [16]. Nevertheless, the possibility of nucleo-
tide binding to the modified βE subunit in solution cannot
be ruled out on the basis of the nucleotide occupancy
observed in the crystal structure.
Biological implications
Adenosine triphosphate (ATP) is the energy currency of
biology, and its synthesis is carried out by the F1F0-ATP
synthase complex. In bovine heart mitochondria, the
complex is found in the inner membrane. The complex is
an assembly of 31 polypeptides of 16 different kinds [23]
with a combined molecular mass of 660,000. The enzyme
uses the proton motive force generated across the mem-
brane from oxidative metabolism to synthesise ATP from
ADP and phosphate. 
A detailed understanding of the biological mechanism of
this enzyme has been derived from the structure of bovine
F1-ATPase at 2.8 Å resolution [16]. The enzyme com-
prises five subunits in the ratio α3β3γδε. The structure
shows that the three catalytic β subunits alternate  with
the three non-catalytic α subunits around the centrally
located γ subunit. Each of the β subunits adopts a different
conformation, with different nucleotide occupancy. One
β subunit (βTP) has AMP-PNP bound, the second (βDP)
has ADP bound and the third (βE) has no bound nucleo-
tide. The structure suggested that the nucleotide-binding
properties of the three catalytic sites of the enzyme were
modulated by the rotation of the central γ subunit inside
the surrounding α3β3 complex. Guided by the structure,
the rotation has been visualised directly in the α3β3γ
complex from a moderately thermophilic bacterium [18].
This rotary mechanism should be able to explain the
modes of action of inhibitors of the enzyme. The crystal
structures of F1-ATPase in complex with the antibiotics
efrapeptin [24] and aurovertin [25] indicated that the mode
of binding of both these inhibitors to F1-ATPase was com-
patible with such a mechanism of catalysis. Another
inhibitor, NBD-Cl, inhibits F1-ATPase by covalent reac-
tion with Tyr311 in one of the three catalytic β subunits.
We report here the structure of F1-ATPase in complex
with NBD-Cl (F1–NBD). The F1–NBD inhibited state
shows that the reagent has reacted with the catalytic
subunit, βE, that has no affinity for nucleotide. The
inhibitor appears to be preventing this subunit from being
changed into a nucleotide-binding state, a change that
would otherwise be brought about by the rotation of the
γ subunit in the active enzyme. Therefore, the structure of
F1–NBD provides further support for the rotary mecha-
nism of ATP synthesis and hydrolysis.
Materials and methods
Inhibition of F1-ATPase by NBD-Cl
Bovine F1-ATPase was purified according to Walker et al. [3], except
that the Ultrogel AcA34 column was replaced by a Pharmacia HiLoad
26/60 Superdex 200 pg column. The purified F1-ATPase, stored as an
ammonium sulphate suspension, was centrifuged at 30,500 g at 4°C.
The resulting pellet was washed in 5 ml of F1–NBD buffer A (250 mM
sucrose, 50 mM MOPS-NaOH pH 7.4, 4 mM ATP, 2 mM EDTA) to
remove all traces of dithiothreitol. The inhibition of F1-ATPase (non-
nucleotide-depleted enzyme) in F1–NBD buffer A was conducted
according to [4], and its course was followed by measuring the
ATPase activity assay, using an ATP regenerating system coupled to
oxidation of NADH. The assay solution (1 ml) contained 83 mM
sucrose, 33 mM Tris-HCl, pH 8.0, 10 mM magnesium chloride, 6 mM
potassium hydrogen carbonate, 5 mM ATP, 5 mM phosphoenol pyru-
vate and 0.25 mM NADH, to which was added pyruvate kinase (8.5 U)
and L-lactate dehydrogenase (7.5 U). The rate of ATP hydrolysis was
calculated from the linear decrease in A340, using a value of 6220 for
the molar extinction coefficient for NADH at 30°C. The reduction of
NBD-Cl inhibited F1 with dithionite was performed as described in [5].
Bound nucleotides were removed from F1–NBD according to [26],
except that the glycerol concentration was 20% (v/v). Fractions with
a total nucleotide content of less than 0.25 mol/mol F1, as deter-
mined by the luciferin-luciferase assay [27], were pooled and used in
crystallization trials.
Crystallization of F1–NBD
Crystallizations were carried out in 50 µl microdialysis buttons, using
SpectraPor cellulose ester dialysis membranes (5000 molecular
weight cut-off) and a protein concentration of 10 mg/ml. Inside buffer
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(100 mM Tris-HCl, pH 7.2, 400 mM sodium chloride, 4 mM magnesium
chloride, 0.04% (w/v) sodium azide, 0.004% (w/v) phenylmethyl-
sulphonyl fluoride, 12% (w/v) polyethylene glycol monomethylether
5000 (PEG MME 5000), 2 mM AMP-PNP and 40 µM ADP) was
added to an equal volume of protein to give a final protein concentra-
tion of 5 mg/ml. This solution was placed in a microdialysis button. The
outside buffer (50 mM Tris-HCl, pH 7.5, 200 mM sodium chloride,
1 mM EDTA, 20 mM magnesium sulphate, 0.02% (w/v) sodium azide,
0.002% (w/v) phenylmethylsulphonyl fluoride, 8% (w/v) PEG MME
5000, 250 µM AMP-PNP and 5 µM ADP) was changed after three
days, and the PEG MME 5000 concentration was increased to values
between 10.5% and 11%. Crystals appeared after two weeks at 23°C.
They were fully grown after six weeks, with typical dimensions of
350 × 150 × 100 µm.
Data collection
Immediately before data collection, ethylene glycol was added over a
period of 7 h to the outside buffer in 4% steps, to a final concentration
of 28% (v/v). X-ray data were collected from a single crystal at 100K
on station 9.6 of the Synchrotron Radiation Source (Daresbury, UK), at
a wavelength of 0.87 Å and recorded on a 300 mm MAR Research
image plate detector. The crystal belongs to the orthorhombic space
group P212121 with unit-cell dimensions 281.0 × 106.6 × 138.8 Å
(1 Å = 0.1 nm), and had a mosaic spread of 0.45°. Data were
processed using MOSFLM [28] and programs from the Collaborative
Computing Project No. 4 suite [29].
Structure solution and refinement
The structure of the F1–NBD complex was solved by molecular replace-
ment. The aluminium fluoride inhibited F1-ATPase complex (KB, RI
Menz, AGWL and JEW, unpublished data) was used as a starting
model. Throughout the refinement of the F1–NBD structure, 2% of the
data were used for calculation of the free R factor [30]. The starting
model gave an initial R factor of 46.1% and free R factor of 44.7%. The
model was then subjected to rigid-body refinement using the program
TNT [31], and all data from 20–3 Å. Further positional refinement using
data from 6–3 Å was carried out using the torsion angle dynamics
option in X-PLOR [32], followed by positional and temperature-factor
refinement using conventional Powell minimisation [32]. The water
structure was then omitted to prevent model bias, and a second round
of refinement by torsion angle dynamics was performed. After this initial
refinement by X-PLOR, a search of the difference density map revealed
significant positive density only around the hydroxyl of Tyr311 in the
βE subunit (Figure 6). The absence of any additional density around
Tyr311 at this position in the native AMP-PNP/ADP bound F1-ATPase
electron-density map, or in either the βTP or βDP subunits suggests that
this feature is attributable to NBD-Cl. Coordinates for an NBD group
were obtained from the entry GAKNEL [33] in the Cambridge small mol-
ecules database. A new entry was created in the X-PLOR dictionary for
a tyrosine residue modified by NBD-Cl. The modified residue was built
into the βE subunit with the graphics program O [34] (Figure 7), with the
bond length and angles for the ester linkage between Tyr311 and the
NBD group taken from the DCPHER entry [35] in the Cambridge small
molecules database. A third round of torsion angle dynamics was per-
formed, to refine the position of the modified tyrosine residue. The
solvent structure was then redetermined, and new water molecules
assigned to positions of peaks in the difference Fourier map greater
than 3.5σ, providing that these made suitable hydrogen-bonding con-
tacts. A final Powell minimisation of the model including the solvent mol-
ecules was performed, and any refined water molecules outside
hydrogen-bonding distance were excluded. The stereochemistry of the
final model was verified using PROCHECK [36].
Accession numbers
The atomic coordinates and structure factors have been deposited with
the Brookhaven Protein Data Bank. The accession codes for the coor-
dinates and structure factors are 1NBM and R1NBMSF, respectively.
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